adr_usa_0485|CYAD|Short Name|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
adr_usa_0485|CYAD|Long Name|Celyad Oncology Total Current Assets (Quarterly) (USD)|Celyad Oncology Cash and Short Term Investments (Quarterly) (USD)|Celyad Oncology Inventories (Quarterly) (USD)|Celyad Oncology Net PP&E (Quarterly) (USD)|Celyad Oncology Goodwill and Intangibles (Quarterly) (USD)|Celyad Oncology Total Liabilities (Quarterly) (USD)|Celyad Oncology Total Current Liabilities (Quarterly) (USD)|Celyad Oncology Total Long Term Liabilities (Quarterly) (USD)|Celyad Oncology Total Deposits (Quarterly) (USD)|Celyad Oncology Book Value (Quarterly) (USD)|Celyad Oncology Retained Earnings (Quarterly) (USD)|Celyad Oncology Treasury Stock (Quarterly) (USD)|Celyad Oncology EV to Revenues|Celyad Oncology EV to Earnings|Celyad Oncology EV to Free Cash Flow|Celyad Oncology EV to Assets (Quarterly)|Celyad Oncology PS Ratio|Celyad Oncology PE Ratio|Celyad Oncology Price to Book Value|Celyad Oncology PEG Ratio|Celyad Oncology Debt to Equity Ratio|Celyad Oncology Dividend Yield|Celyad Oncology Shareholder Yield (TTM)|Celyad Oncology Percent of Shares Outstanding Short|Celyad Oncology Total Receivables (Quarterly) (USD)|Celyad Oncology Total Payables (Quarterly) (USD)|Celyad Oncology Total Capital Stock (Quarterly) (USD)|Celyad Oncology Return on Invested Capital|Celyad Oncology Quality Ratio Score|Celyad Oncology Momentum Score|Celyad Oncology Beta (1Y)|Celyad Oncology Sustainable Growth Rate (TTM)|Celyad Oncology Institutional Investor Ownership Percentage|Celyad Oncology Average Diluted Shares Outstanding (Quarterly)|Celyad Oncology Total Employees (Annual)|Celyad Oncology EPS Diluted (Quarterly) (USD)|Celyad Oncology Dividend Per Share (Quarterly) (USD)|Celyad Oncology Revenue (Quarterly) (USD)|Celyad Oncology Gross Profit (Quarterly) (USD)|Celyad Oncology SG&A Expense (Quarterly) (USD)|Celyad Oncology Pre-Tax Income (Quarterly) (USD)|Celyad Oncology Net Income (Quarterly) (USD)|Celyad Oncology Net Interest Income (Quarterly) (USD)|Celyad Oncology Price (USD)|Celyad Oncology Total Return Price (USD)|Celyad Oncology Enterprise Value (USD)|Celyad Oncology 30-Day Average Daily Volume|Celyad Oncology 1 Year Price Returns (Daily)||
adr_usa_0485|CYAD|Unit|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
adr_usa_0485|CYAD|201212|3.0902|2.1756||0.5067|12.7155|19.5002|4.601|14.8992||-2.9887|-32.5955||||||||||0||||0.5857|2.4157|13.1913||||||||46|||||||||||||||
adr_usa_0485|CYAD|201306|6.509|5.1389||0.3783|12.4614|21.0708|5.1541|15.9167||-1.4622|-39.7109||||||||||0||||0.3949|3.4598|21.4845|||||||||||||||||||||||
adr_usa_0485|CYAD|201312|31.2111|30.4596||0.3358|12.9803|21.3868|4.6795|16.7073||23.334|-50.2477||||||||||0||||0.5817|3.1377|30.5697|-307.7263||||-307.7263|||51|||||||||||||||
adr_usa_0485|CYAD|201406|57.6301|54.6694||0.5478|12.3653|22.0021|5.9778|16.0243||48.6747|-57.6944||||||||||0||||0.1705|4.1471|33.5303|-83.8835||||-83.8835||||||||||||||||||
adr_usa_0485|CYAD|201412|40.0496|36.8503||0.7272|12.4837|21.0274|7.3606|13.6668||32.4483|-86.5989||||||||||0||||2.0879|4.9152|29.9323|-61.262||||-61.262||||||||||||||||||
adr_usa_0485|CYAD|201506|140.9436|138.8417||0.7661|63.7327|65.5115|9.6446|55.8669||140.0744|-96.4531|||-11.6949|-14.2513|1.6798|||10.9268|-0.2221|0|0||0.0338|0.8221|7.1726|36.5081|-40.0497||||-40.0497||||||||||||52.72|52.72|334.3196|||49.4|49.4
adr_usa_0485|CYAD|201509|||||||||||||||-9.7551||||2.7476|-0.1766||0||0.4162||||||||||||||||||||41.35|41.35|246.0317|2890.1||39.25|39.25
adr_usa_0485|CYAD|201512|119.6278|117.544||1.242|53.341|52.5353|12.562|39.9732||121.8734|-109.6722|||-12.2067|-13.7556|2.2412|||3.4679|-0.2228|0|0||0.072|1.1753|9.3761|35.6099|-32.6318||||-32.6318|||88|||||||||52.1899|52.1899|346.9262|13795.6667||49.91|49.91
adr_usa_0485|CYAD|201603|||||||||||||||-9.9046||||3.4764|-0.5138||0||0.2915||||||||||||||||||||45.49|45.49|306.1317|3323.9||44.52|44.52
adr_usa_0485|CYAD|201606|98.2463|95.6957||4.0244|53.2344|48.2366|10.3781|37.8585||107.4832|-130.4096||2865.4241|-4.062|-4.0919|0.892|4886.4342||2.0022|-0.4827|0.018|0||0.6278|1.5206|6.4393|36.23|-27.6228|||1.3283|-27.7677||||||||||||26.2|26.2|126.4724|9977.9667|-19.4803|25|25
adr_usa_0485|CYAD|201609|||||||||||||2177.563||-2.4065||4186.1365||1.8543|-0.3532||0||0.1288||||||2|1.0084|||||||||||||21.4|21.4|105.553|1643.2|-50.1166|22.2|22.2
adr_usa_0485|CYAD|201612|90.2466|87.3077||3.7667|52.3992|50.6602|11.9195|38.7407||96.0789|-131.1153||1514.6802|-2.9962|-1.6739|0.5376|3511.2687||1.5554|-0.2963|0.0082|0||0.0327|1.5889|8.5609|34.4328|-24.0698||1|3.6511|-24.2712|||85|||||||||17.95|17.95|73.4211|6204.4333|-64.2644|18.88|18.88
adr_usa_0485|CYAD|201703|||||||||||||14.4644||-5.2641||21.9841||2.5269|||0||0.0129||||||1|4.0422|||||||||||||25.5|25.5|156.2607|2049.7333|-43.9437|29.31|29.31
adr_usa_0485|CYAD|201706|81.0619|78.7431||3.4936|52.7208|49.2386|14.6687|34.5699||88.3705|-158.3682||29.466|-14.1555|-10.7238|2.3728|36.6402||4.2137||0.0155|0||0.0272|1.5077|5.285|37.8999|-23.3764||3|2.6232|-23.7042||||||||||||42.5|42.5|318.3243|1709.9667|0.1178|41.68|41.68
adr_usa_0485|CYAD|201709|||||||||||||32.401||-22.6169||35.9304||6.2339|||0||0.0162||||||10|1.7328|||||||||||||55.86|55.86|473.5198|2107.3|157.538|61.92|61.92
adr_usa_0485|CYAD|201712|43.6619|40.677||3.947|43.7986|36.1002|9.5316|26.5686||57.0277|-216.4511||20.796|-5.9003|-16.6183|4.137|24.8541||4.3147||0.0113|0||0.833|1.9099|5.7586|41.1941|-80.191||9|-7.7662|-81.1205|||77|||||||||43.1|43.1|347.9307|4529.3|138.7812|46.5|46.5
adr_usa_0485|CYAD|201803|||||||||||||80.279||-6.1276||88.3062||6.1888|-0.0662||0||1.283|||||||1.4638|||||||||||||36.46|36.46|319.9089|2697.2667|67.7363|34|34
adr_usa_0485|CYAD|201806|77.4695|73.1048||3.6397|40.7749|42.0548|11.7159|30.339||84.038|-229.947||79.3803|-3.9517|-5.9262|2.24|72.2753||6.1274|-0.0542|0.009|0||1.0389|0.3133|7.4471|48.044|-92.3452||2|1.0828|-93.4586||||||||||||29.26|29.26|309.3965|21196.1667|-34.0516|31.24|31.24
adr_usa_0485|CYAD|201809|||||||||||||86.0927||-4.9276||92.4157||3.9832|-0.0363||0||1.2255||||||2|1.6657|||||||||||||28.03|28.03|262.3905|8075.8|-48.71|25|25
adr_usa_0485|CYAD|201812|59.1305|56.8964||3.4477|41.368|44.2804|11.0352|33.2452||63.5905|-249.1163||41.4232|-3.6756|-2.3709|1.4885|54.8296||2.3632|-0.0219|0.0092|0||0.6812|1.4516|6.7673|47.5325|-63.4194||3|1.9787|-64.0323|||96|||||||||16.63|16.63|126.2483|9440.3667|-56.9617|19.76|19.76
adr_usa_0485|CYAD|201903|||||||||||||50.1455||-5.46||61.0335||3.7936|-0.1324||0||0.6869||||||2|2.0741|||||||||||||20.2|20.2|184.9214|4380.1333|-43.4965|20.95|20.95
adr_usa_0485|CYAD|201906|40.3351|38.2805||6.2819|41.0309|45.9791|10.1375|35.8417||46.5249|-69.8755||20.1577|-2.5044|-2.1949|1.0715|33.0548||2.0545|-0.076|0.009|0||0.8255|0.4525|6.1841|47.2458|-60.605||3|0.9758|-61.1526|7.757|||||||||||10.94|10.94|74.3357|9703.5667|-62.6111|13.4956|13.4956
adr_usa_0485|CYAD|201909|||||||||||||||-2.8094||||2.9248|-0.0849||0||0.1545||||||2|0.7409|||||||||||||9.76|9.76|98.2147|52628.3|-65.1802|10|10
adr_usa_0485|CYAD|201912|47.9836|44.0652||5.6692|40.549|49.5306|13.3547|36.1759||51.101|-83.3675|||-3.1748|-2.6937|1.0083|||2.8379|-0.0901|0.005|0||2.2695|3.0267|7.8065|54.3428|-59.0151||2|0.0569|-59.4757|13.068||107|||||||||9.47|9.47|94.1715|59931.7|-43.0547|11.25|11.25
adr_usa_0485|CYAD|202003|||||||||||||||-2.1351||||2.2018|||0||1.8128||||||2|0.237||21.1106|||||||||||8.07|8.07|68.7056|17860.5667|-60.4412|7.39|7.39
adr_usa_0485|CYAD|202006|33.1092|30.0197||4.7585|40.6073|51.1073|12.1442|38.9631||34.0977|-102.3686|||-3.6875|-3.9598|1.3981|||4.3711||0.003|0||0.0566|2.3877|6.5028|54.5611|-73.1432||3|1.5902|-73.5748|9.1248|||||||||||10.69|10.69|119.1258|28108.5667|-6.8003|10.13|10.13
adr_usa_0485|CYAD|202009|||||||||||||8897.3272||-3.5936||11017.9692||4.048|||0||1.5946||||||4|1.4321||9.1256|||||||||||9.9|9.9|108.1114|7594.3|3.125|9.486|9.486